Position in PRGO
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$540
+$471 QoQ
Shares Held
52
+940.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#303
of 334 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Capital Advisors, Ltd. LLC holds $70,367 across 17 Drug Manufacturers - Specialty & Generic names. PRGO ranks #9 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,855 | $29,457 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
65 | $10,955 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
173 | $8,046 | |
| 4 | ZTS |
Zoetis Inc.
|
99 | $7,114 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
13 | $7,043 | |
| 6 | CPIX |
Cumberland Pharmaceuticals Inc
|
437 | $2,831 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
54 | $1,872 | |
| 8 | PAHC |
Phibro Animal Health Corp
|
22 | $690 |
All Filings in PRGO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $540 | 52 | Shares | Sole | 2026-07-16 | |
| 2025-12-31 | $69 | 5 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1 | 37 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $2,939 | 110 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $3,196 | 114 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $6,915 | 269 | Shares | Sole | 2025-02-04 | |
| 2023-12-31 | $3,861 | 120 | Shares | Sole | 2024-02-02 | |
| 2023-06-30 | $101 | 3 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $322 | 9 | Shares | Sole | 2023-05-03 | |
| No filing history on record for this holder in this stock. | ||||||